Internal Medicine · 2008 · 38 citations · 13 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyDrug Utilization ReviewSteroid BiochemistryMyasthenia GravisSteroid PharmacologyLong-term Side EffectsMyasthenia Gravis PharmacotherapySerious Adverse Drug ReactionsSteroid Adverse EffectsSteroid-related Side Effect ManagementSteroid-sparing ImmunosuppressantsTacrolimus Pharmacokinetics
OBJECTIVE: To examine the long-term effects of tacrolimus in steroid-dependent myasthenia gravis (MG) patients. PATIENTS AND METHODS: We administered tacrolimus at 3 mg/day to 10 generalized MG patients presented with clinical worsening by a reduction in dose of prednisolone. The effects of tacrolimus were assessed by using the MG activities of daily living (MG-ADL) profile and the post-intervention status criteria provided by the Myasthenia Gravis Foundation of America (PSC-MGFA). RESULTS: Seven patients were able to use tacrolimus without serious adverse effects for 1.0-5.1 years (mean 3.1 years). Further, its administration improved myasthenic symptoms to the level of pharmacologic remission or minimal manifestations of PSC-MGFA in 5 patients and made it possible to discontinue prednisolone administration in 4 of those 5. However, despite improvements caused by tacrolimus, the reduction in dose of prednisolone caused worsening of symptoms in another 2 patients. In addition, blood trough levels of tacrolimus lower than the recommended range were effective to maintain long-term improvements in 2 patients. CONCLUSIONS: Administration of tacrolimus induced long-term improvements and enabled replacement of prednisolone in patients with intractable steroid-dependent MG.
13
Myasthenia gravis activities of daily living profile
Gil I. Wolfe, Laura Herbelin, Sharon Nations et al. · Neurology · 1999 · 544 citations
A.P. Timerman, E Ogunbumni, Eileen A. Freund et al. · Journal of Biological Chemistry · 1993 · 351 citations · Full text
Medicine, Cell Biology, Pharmacology +15
Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis
Masaharu Takamori, Masakatsu Motomura, Naoki Kawaguchi et al. · Neurology · 2004 · 74 citations